Evaluating the AVanCer Program for Stroke and Brain Injury Rehabilitation
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
This study is testing the AVanCer rehabilitation program to see if it helps stroke and brain injury patients regain independence and improve the well-being of their caregivers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 162 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Trial ID | NCT05795686 on ClinicalTrials.gov |
What this trial studies
This study evaluates the AVanCer program provided by the ARRPAC Day Center in France, focusing on rehabilitation for patients who have suffered strokes or brain injuries. It aims to assess the impact of this program on patient autonomy and the well-being of caregivers. Participants will include both patients selected for the program and their caregivers, who will provide feedback through assessments and questionnaires. The study seeks to address the significant challenges faced by individuals recovering from these conditions and their families.
Who should consider this trial
Good fit: Ideal candidates include adults who have experienced a stroke or brain injury and are starting the AVanCer program at the ARRPAC center.
Not a fit: Patients who do not speak or understand French may not benefit from this study due to language barriers in communication and assessment.
Why it matters
Potential benefit: If successful, this program could enhance rehabilitation outcomes and improve the quality of life for stroke and brain injury patients and their caregivers.
How similar studies have performed: Other studies have shown success in rehabilitation programs for stroke and brain injury, indicating that this approach has potential based on previous findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For patients : * Male or female of legal age * Patient who has been selected to start the AVanCer program at the ARRPAC center * Patient who has agreed to participate in the PATIENT assessment component and has signed the consent form * Patient able to speak and understand French both orally and in writing For caregivers : * Male or female of legal age * Person who has agreed to participate in the CAREGIVING assessment component and has signed the consent form * Person able to speak and understand French both orally and in writing Population of the qualitative study : * Voluntary patients and caregivers who participated in the quantitative part (follow-up by questionnaires) * Partner professionals: a sample of 10 representatives of ARRPAC partners who referred people for support during the first 12 months, from the following structures: public Medicine, Surgery, Obstetric health institution, private Medicine, Surgery, Obstetric health institution, public Follow-up and Rehabilitation Care institution, private Follow-up and Rehabilitation Care institution, medico-social institution, town professionals and user associations. * ARRPAC professionals: the 14 ARRPAC professionals involved in the day care centre will be interviewed in a semi-structured manner Exclusion Criteria: * Pregnant women, parturient or breastfeeding mothers\* * Persons deprived of their liberty by a judicial or administrative decision * Persons under psychiatric care * Persons admitted to a health or social establishment for purposes other than research * Persons of full age subject to a legal protection measure (guardian, curators) * Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Where this trial is running
Bron
- Accueil de jour ARRPAC — Bron, France (Recruiting)
Study contacts
- Study coordinator: Julie Haesebaert, MD
- Email: julie.haesebaert01@chu-lyon.fr
- Phone: 06-51-42-97-43
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.